EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,462,248 | -37.6% | 282,958 | -23.1% | 0.01% | -40.0% |
Q2 2023 | $7,153,395 | -5.0% | 367,973 | +38.6% | 0.02% | -11.8% |
Q1 2023 | $7,529,965 | +90.4% | 265,420 | +96.1% | 0.02% | +88.9% |
Q4 2022 | $3,955,257 | +56.1% | 135,315 | +41.1% | 0.01% | +50.0% |
Q3 2022 | $2,534,000 | +11.1% | 95,915 | +86.9% | 0.01% | +20.0% |
Q2 2022 | $2,280,000 | +9.8% | 51,316 | +22.3% | 0.01% | +25.0% |
Q1 2022 | $2,077,000 | -13.6% | 41,963 | -11.1% | 0.00% | 0.0% |
Q4 2021 | $2,405,000 | -9.1% | 47,225 | -0.4% | 0.00% | -20.0% |
Q3 2021 | $2,646,000 | +11.0% | 47,434 | -14.9% | 0.01% | +25.0% |
Q2 2021 | $2,384,000 | -7.0% | 55,707 | -9.3% | 0.00% | 0.0% |
Q1 2021 | $2,563,000 | +23.2% | 61,409 | +37.4% | 0.00% | 0.0% |
Q4 2020 | $2,081,000 | -25.2% | 44,685 | -31.8% | 0.00% | -20.0% |
Q3 2020 | $2,782,000 | -37.1% | 65,499 | -29.0% | 0.01% | -28.6% |
Q2 2020 | $4,424,000 | -33.5% | 92,199 | -36.2% | 0.01% | -36.4% |
Q1 2020 | $6,652,000 | -13.2% | 144,617 | +13.4% | 0.01% | +22.2% |
Q4 2019 | $7,660,000 | +19.5% | 127,496 | +12.5% | 0.01% | +12.5% |
Q3 2019 | $6,409,000 | +0.6% | 113,301 | -1.0% | 0.01% | +14.3% |
Q2 2019 | $6,370,000 | +16.9% | 114,406 | +6.0% | 0.01% | +16.7% |
Q1 2019 | $5,451,000 | +38.8% | 107,954 | +10.8% | 0.01% | +20.0% |
Q4 2018 | $3,926,000 | -17.1% | 97,435 | +42.6% | 0.01% | 0.0% |
Q3 2018 | $4,738,000 | +31.0% | 68,344 | +43.0% | 0.01% | +25.0% |
Q2 2018 | $3,616,000 | +6.6% | 47,795 | -25.8% | 0.00% | 0.0% |
Q1 2018 | $3,393,000 | -60.0% | 64,390 | -59.5% | 0.00% | -55.6% |
Q4 2017 | $8,487,000 | -29.1% | 158,869 | -20.8% | 0.01% | -35.7% |
Q3 2017 | $11,966,000 | +38.4% | 200,634 | +83.0% | 0.01% | +27.3% |
Q2 2017 | $8,649,000 | +201.9% | 109,637 | +217.4% | 0.01% | +175.0% |
Q1 2017 | $2,865,000 | +82.4% | 34,547 | +74.4% | 0.00% | +100.0% |
Q4 2016 | $1,571,000 | +12.9% | 19,804 | -0.4% | 0.00% | 0.0% |
Q3 2016 | $1,391,000 | +16.0% | 19,875 | -35.7% | 0.00% | 0.0% |
Q2 2016 | $1,199,000 | -16.6% | 30,899 | -12.9% | 0.00% | -33.3% |
Q1 2016 | $1,437,000 | -41.3% | 35,476 | +28.6% | 0.00% | -25.0% |
Q4 2015 | $2,447,000 | -25.8% | 27,597 | -38.0% | 0.00% | -42.9% |
Q3 2015 | $3,297,000 | +49.0% | 44,534 | +62.7% | 0.01% | +75.0% |
Q2 2015 | $2,213,000 | +521.6% | 27,372 | +222.0% | 0.00% | +300.0% |
Q1 2015 | $356,000 | – | 8,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |